Literature DB >> 21858488

[Gastrointestinal tumors. Clinical manifestations of paraneoplastic rheumatic symptoms].

W-J Mayet1.   

Abstract

Paraneoplastic syndromes, as syndromes associated with malignancy, can present unrelated to tumor invasion or metastases. They can occur with varying clinical appearance and are often indistinguishable from idiopathic rheumatic symptoms. Some musculoskeletal disorders are more associated with malignancies. The therapy of rheumatic syndromes can itself have an effect on the tumorigenic process. The clinical severity of paraneoplastic rheumatic symptoms can in many cases aid in the assessment of tumor activity and the response to therapy. While generally an extensive search for occult malignancies in every older rheumatoid patient in cases with no indications of malignancy is not advisable, knowledge of rheumatic symptoms associated with malignancies aids in the important early detection of tumors, while avoiding unnecessary examinations.

Entities:  

Mesh:

Year:  2011        PMID: 21858488     DOI: 10.1007/s00393-011-0812-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  31 in total

1.  Paraneoplastic Raynaud's phenomenon.

Authors:  A J DeCross; D M Sahasrabudhe
Journal:  Am J Med       Date:  1992-05       Impact factor: 4.965

Review 2.  Cancer in autoimmune diseases.

Authors:  O Sela; Y Shoenfeld
Journal:  Semin Arthritis Rheum       Date:  1988-11       Impact factor: 5.532

3.  Reflex sympathetic dystrophy as a probable paraneoplastic syndrome: case report and literature review.

Authors:  R M Michaels; J A Sorber
Journal:  Arthritis Rheum       Date:  1984-10

4.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

5.  Prognostic significance of paraproteinaemia in rheumatoid arthritis.

Authors:  C Kelly; G Baird; H Foster; H Hosker; I Griffiths
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

6.  Malignancy and biologic therapy in rheumatoid arthritis.

Authors:  Johan Askling; Tim Bongartz
Journal:  Curr Opin Rheumatol       Date:  2008-05       Impact factor: 5.006

Review 7.  Arterial occlusive disease in occult cancer.

Authors:  J E Naschitz; D Yeshurun; J Abrahamson
Journal:  Am Heart J       Date:  1992-09       Impact factor: 4.749

Review 8.  Epstein-Barr virus in autoimmune diseases.

Authors:  Eric Toussirot; Jean Roudier
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-10       Impact factor: 4.098

9.  Rheumatic manifestations of occult cancer.

Authors:  J E Naschitz; D Yeshurun; I Rosner
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

10.  Elevated cancer incidence in patients with dermatomyositis: a population based study.

Authors:  A Airio; E Pukkala; H Isomäki
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.